设为首页 电子邮箱 联系我们

本刊最新招聘信息请见“通知公告”!  本刊投稿系统试运行中,欢迎投稿!如投稿有问题,可直接将稿件发送至zgyy8888@163.com

 

主管单位:中华人民共和国   

国家卫生健康委员会

主办单位:中国医师协会
总编辑:
杨秋

编辑部主任:吴翔宇

邮发代号:80-528
定价:28.00元
全年:336.00元
Email:zgyy8888@163.com
电话(传真):010-64428528;
010-64456116(总编室)

                  

过刊目录

2020 年第 11 期 第 15 卷

乌司他丁联合右美托咪定对单肺通气患者的肺保护作用研究

Research on the lung protection of ulinastatin combined with dexmedetomidine in patients with single-lung ventilation

作者:郭宗锋1颜永进2张晨2陈为国1王祥1徐卫东3

英文作者:Guo Zongfeng1 Yan Yongjin2 Zhang Chen2 Chen Weiguo1 Wang Xiang1 Xu Weidong3

单位:1南通大学附属海安医院麻醉科226600;2南通大学附属海安医院中心实验室226600;3南通大学附属海安医院药剂科226600

英文单位:1Department of Anesthesiology Hai′an Hospital Affiliated to Nantong University Jiangsu Province Nantong 226600 China; 2Central Laboratory Hai′an Hospital Affiliated to Nantong University Jiangsu Province Nantong 226600 China; 3Department of Pharmacy Hai′an Hospital Affiliated to Nantong University Jiangsu Province Nantong 226600 China

关键词:单肺通气;肺保护;乌司他丁;右美托咪定

英文关键词:Single-lungventilation;Lungprotection;Ulinastatin;Dexmedetomidine

  • 摘要:
  • 目的 探讨乌司他丁联合右美托咪定对单肺通气患者的肺保护作用。方法 选择20191月至20201月在南通大学附属海安医院需要进行胸腔镜下肺叶切除术的患者100 例,按随机数字表法分为对照组(N组)、乌司他丁组(U组)、右美托咪定组(D组)、联合组(U+D组),各25例。麻醉诱导前各组分别给药。比较4组单肺通气开始时即刻(T1)、单肺通气后30 min(T2)、术毕(T3)的肺动态顺应性(Cdyn)、氧合指数、呼吸指数,给药前(T0)T2T3、手术后12 h(T4)的炎症因子水平,包括血清白细胞介素2IL-2)、IL-6IL-10和肿瘤坏死因子α(TNF-α)。记录4组术后肺部并发症(PPCS)发生情况和住院时间。结果 T1T3时点,所有患者的Cdyn、氧合指数先下降后升高,呼吸指数先升高再下降(均P0.05)。T3时点,U+D组的Cdyn、氧合指数显著高于NUD组[(31±4ml/cmH2O1 cmH2O=0.098 kPa)比(24±4)、(29±4)、(28±4ml/cmH2O,(349±22mmHg1 mmHg=0.133 kPa)比(328±21)、(336±21)、(335±20mmHg];呼吸指数显著低于NUD组[(0.46±0.10)比(0.97±0.13)、(0.87±0.14)、(0.89±0.12)](均P0.05)。从T0T4时点,4组患者所有炎症因子水平均先上升再下降(均P0.05)。T3T4时点,U+D组的促炎因子(IL-2IL-6TNF-α)水平显著低于NUD组,抗炎因子(IL-10)水平显著高于NUD组(均P0.05)。U+D组的PPCS发生率显著低于UDN组,术后住院时间短于UDN组(均P0.05)。结论 乌司他丁、右美托咪定可在一定程度上减轻单肺通气对肺部造成的损伤,两药联用时效果最好。

  • Objective To explore the protective effect of ulinastatin combined with dexmedetomidine on patients with single-lung ventilation. Methods From January 2019 to January 2020 100 patients who needed thoracoscopic lobectomy in Haian Hospital Affiliated to Nantong University were selected. They were randomly divided into the control group (N group) ulinastatin group (U group), dexmedetomidine group (D group) and combination group (U+D group), with 25 cases in each group. Each group was given medicine before anesthesia induction. The dynamic lung compliance (Cdyn), oxygenation index and respiratory index at the beginning of single-lung ventilation (T1), 30 min after single-lung ventilation (T2) and the end of operation (T3), and the levels of inflammatory factors at before administration (T0), T2, T3 and 12 h after operation (T4), including serum interleukin-2 (IL-2), IL-6, IL-10 and tumor necrosis factor-α (TNF-α) in four groups were compared. The occurrence of postoperative pulmonary complications (PPCS) and the length of hospital stay in the four groups were recorded. Results From T1 to T3, the Cdyn and oxygenation index of all patients decreased firstly and then increased, and the respiratory index increased firstly and then decreased (all P0.05). At T3, the Cdyn and oxygenation index in the U+D group were significantly higher than those in the N, U and D groups[(31±4ml/cmH2O vs 24±4,29±4,28±4ml/cmH2O;349±22mmHg vs 328±21,336±21,335±20mmHg, respiration index was significantly lower than that of N, U, D group[(0.46±0.10 vs 0.97±0.13,0.87±0.14,0.89±0.12)](all P0.05). From T0 to T4, all inflammatory factors levels in the four groups increased firstly and then decreased (all P0.05). At T3 and T4, the levels of pro-inflammatory factors (IL-2, IL-6 and TNF-α) in the U+D group were significantly lower than those in the N, U, and D groups, and the anti-inflammatory factors (IL-10) level was significantly higher than that in the N, U and D groups (all P0.05). The incidence of PPCS and length of postoperative hospital stay in U+D group were significantly lower than those in U, D and N groups (all P0.05). ConclusionUlinastatin and dexmedetomidine can reduce the lung damage caused by single-lung ventilation to a certain extent, and the effect is best when the two drugs are used in combination.

copyright 《中国医药》杂志编辑部
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层
电话:010-64456116 传真:010-64428528 邮编:100029 Email: zgyy8888@163.com
网址:www.chinamedicinej.com 京ICP备2020043099号-3

当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com。







安卓


苹果

关闭